Latest Articles

Publication Date
What is the clinical importance of ultrasound imaging in managing deep endometriosis?

Published: Dec. 22, 2025, midnight
Atosiban as a potential treatment for endometriosis-related pain: results from the ENDOBAN pilot study.

Published: Dec. 22, 2025, midnight
Systematic analyses uncover endocrine-disrupting chemical-responsive genes linked to endometriosis.

Endometriosis is a chronic, estrogen-dependent disorder influenced by both genetic and environmental factors, including endocrine-disrupting chemicals (EDCs). This study aimed to identify EDC-responsive genes contributing to endometriosis risk by integrating …

Published: Dec. 22, 2025, midnight
Endometriosis Researchers Are One Step Closer To New Diagnosis and Treatment Options - Medical Tech Outlook

Endometriosis Researchers Are One Step Closer To New Diagnosis and Treatment Options Medical Tech Outlook

Published: Dec. 21, 2025, 10:05 p.m.
Content creator Lottie Bie reveals she's a new mom - PEP.ph

Content creator Lottie Bie reveals she's a new mom PEP.ph

Published: Dec. 21, 2025, 2:56 p.m.
Adenosarcoma of the uterine cervix – a novel case report and review of the literature - Termedia

Adenosarcoma of the uterine cervix – a novel case report and review of the literature Termedia

Published: Dec. 21, 2025, 8:41 a.m.
Dow Update: What dividend safety score for REPX stock - 2025 Risk Factors & Free Expert Verified Stock Movement Alerts - moha.gov.vn

Dow Update: What dividend safety score for REPX stock - 2025 Risk Factors & Free Expert Verified Stock Movement Alerts moha.gov.vn

Published: Dec. 21, 2025, 8:03 a.m.
Dysmenorrhoea presentation in Herlyn-Werner-Wunderlich syndrome: A case study.

Herlyn-Werner-Wunderlich syndrome is a rare congenital anomaly characterized by uterus didelphys, obstructed hemi-vagina, and ipsilateral renal agenesis. This study aims to present a case of Herlyn-Werner-Wunderlich syndrome seen at Shifa …

Published: Dec. 20, 2025, midnight
Pharmacokinetic-Pharmacodynamic Modeling and Simulation of Merigolix, a Nonpeptide Gonadotropin-Releasing Hormone Antagonist.

Gonadotropin-releasing hormone (GnRH) antagonists inhibit estrogen synthesis and secretion, making them promising treatment options for estrogen-dependent diseases, such as endometriosis. This study developed a population pharmacokinetic/pharmacodynamic (PK/PD) model for merigolix, …

Published: Dec. 20, 2025, midnight
Copper Intrauterine Device Migration Into Cesarean Scar Niches Without Complications: A Case Report.

Intrauterine devices (IUDs), both hormonal and nonhormonal, are widely used contraceptive methods, with approximately 20% of reproductive-aged women worldwide utilizing them. Although IUDs are generally considered safe and effective, complications …

Published: Dec. 20, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!